Cargando…
Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation
Human immunodeficiency virus type 1 (HIV-1) causes a chronic infection that afflicts more than 30 million individuals worldwide. While the infection can be suppressed with potent antiretroviral therapies, individuals infected with HIV-1 have elevated levels of inflammation as indicated by increased...
Autores principales: | Swartz, Talia H., Dubyak, George R., Chen, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659914/ https://www.ncbi.nlm.nih.gov/pubmed/26635799 http://dx.doi.org/10.3389/fimmu.2015.00585 |
Ejemplares similares
-
Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion
por: Freeman, Tracey L., et al.
Publicado: (2020) -
Purinergic Signaling in Pulmonary Inflammation
por: Le, Thanh-Thuy T., et al.
Publicado: (2019) -
Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021) -
Control of Gut Inflammation by Modulation of Purinergic Signaling
por: Vuerich, Marta, et al.
Publicado: (2020) -
Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis
por: Wang, Xu, et al.
Publicado: (2021)